PharVision Advisers’s Rogers Corp ROG Stock Holding History

PharVision Advisers’s Portfolio ROG Stock Details ROG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,822	Closed	-$262K	–	772
2025 Q2	$262K	Buy	+3,822	New	+$246K	0.38%	117

Other funds holding ROG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PharVision Advisers's ROG Position: Q3 2025 in Review

PharVision Advisers sold out of Rogers Corp (ROG) in Q3 2025, closing a stake of 3,822 shares — an estimated $262K sold.

PharVision Advisers first reported a position in ROG in Q2 2025 and held it in 1 quarter. The position peaked at $262K in Q2 2025. 229 funds tracked by Wall St. Rank hold ROG as of Q3 2025.

PharVision Advisers reported no remaining Rogers Corp position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 3,822 Rogers Corp shares in Q3 2025, an estimated $262K.
PharVision Advisers first reported a position in Rogers Corp in Q2 2025 and held it in 1 quarter.
PharVision Advisers's Rogers Corp position peaked at $262K in Q2 2025.
229 funds tracked by Wall St. Rank held Rogers Corp as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.